These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 26639447)

  • 41. Othello syndrome in patients with Parkinson's disease.
    Georgiev D; Danieli A; Ocepek L; Novak D; Zupancic-Kriznar N; Trost M; Pirtosek Z
    Psychiatr Danub; 2010 Mar; 22(1):94-8. PubMed ID: 20305599
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dopaminergic agonists in the treatment of Parkinson's disease: a review.
    Piccoli F; Riuggeri RM
    J Neural Transm Suppl; 1995; 45():187-95. PubMed ID: 8748625
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Association of dopamine agonist use with impulse control disorders in Parkinson disease.
    Weintraub D; Siderowf AD; Potenza MN; Goveas J; Morales KH; Duda JE; Moberg PJ; Stern MB
    Arch Neurol; 2006 Jul; 63(7):969-73. PubMed ID: 16831966
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fronto-striatal atrophy correlates of inhibitory dysfunction in Parkinson's disease versus behavioural variant frontotemporal dementia.
    O'Callaghan C; Naismith SL; Hodges JR; Lewis SJ; Hornberger M
    Cortex; 2013; 49(7):1833-43. PubMed ID: 23306064
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dopaminergic system and dream recall: An MRI study in Parkinson's disease patients.
    De Gennaro L; Lanteri O; Piras F; Scarpelli S; Assogna F; Ferrara M; Caltagirone C; Spalletta G
    Hum Brain Mapp; 2016 Mar; 37(3):1136-47. PubMed ID: 26704150
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Impulse control and related disorders in Mexican Parkinson's disease patients.
    Rodríguez-Violante M; González-Latapi P; Cervantes-Arriaga A; Camacho-Ordoñez A; Weintraub D
    Parkinsonism Relat Disord; 2014 Aug; 20(8):907-10. PubMed ID: 24935236
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Creative innovation with temporal lobe epilepsy and lobectomy.
    Ghacibeh GA; Heilman KM
    J Neurol Sci; 2013 Jan; 324(1-2):45-8. PubMed ID: 23117152
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dopaminergic agonists in Parkinson's disease.
    Alonso Cánovas A; Luquin Piudo R; García Ruiz-Espiga P; Burguera JA; Campos Arillo V; Castro A; Linazasoro G; López Del Val J; Vela L; Martínez Castrillo JC
    Neurologia; 2014 May; 29(4):230-41. PubMed ID: 21724302
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Alexithymia-an independent risk factor for impulsive-compulsive disorders in Parkinson's disease.
    Goerlich-Dobre KS; Probst C; Winter L; Witt K; Deuschl G; Möller B; van Eimeren T
    Mov Disord; 2014 Feb; 29(2):214-20. PubMed ID: 24123483
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The use of antidepressant medication in Parkinson's disease patients is not affected by the type of antiparkinson medication.
    Krøigård T; Christensen J; Wermuth L; Ritz B; Lassen CF
    J Parkinsons Dis; 2014; 4(3):327-30. PubMed ID: 24919822
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Parkinson's disease duration determines effect of dopaminergic therapy on ventral striatum function.
    MacDonald AA; Monchi O; Seergobin KN; Ganjavi H; Tamjeedi R; MacDonald PA
    Mov Disord; 2013 Feb; 28(2):153-60. PubMed ID: 23165957
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of dopamine agonist dose and gender on the prognosis of impulse control disorders in Parkinson's disease.
    Joutsa J; Martikainen K; Vahlberg T; Kaasinen V
    Parkinsonism Relat Disord; 2012 Dec; 18(10):1079-83. PubMed ID: 22784693
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Novelty seeking behaviour in Parkinson's disease.
    Djamshidian A; O'Sullivan SS; Wittmann BC; Lees AJ; Averbeck BB
    Neuropsychologia; 2011 Jul; 49(9):2483-8. PubMed ID: 21565210
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Visual artistic creativity and the brain.
    Heilman KM; Acosta LM
    Prog Brain Res; 2013; 204():19-43. PubMed ID: 24041317
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Subthalamic stimulation in Parkinson's disease: restoring the balance of motivated behaviours.
    Lhommée E; Klinger H; Thobois S; Schmitt E; Ardouin C; Bichon A; Kistner A; Fraix V; Xie J; Aya Kombo M; Chabardès S; Seigneuret E; Benabid AL; Mertens P; Polo G; Carnicella S; Quesada JL; Bosson JL; Broussolle E; Pollak P; Krack P
    Brain; 2012 May; 135(Pt 5):1463-77. PubMed ID: 22508959
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impulse control disorders and dopaminergic treatments in Parkinson's disease.
    Villa C; Pascual-Sedano B; Pagonabarraga J; Kulisevsky J
    Rev Neurol (Paris); 2011 Nov; 167(11):827-32. PubMed ID: 21596410
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Acting without being in control: Exploring volition in Parkinson's disease with impulsive compulsive behaviours.
    Ricciardi L; Haggard P; de Boer L; Sorbera C; Stenner MP; Morgante F; Edwards MJ
    Parkinsonism Relat Disord; 2017 Jul; 40():51-57. PubMed ID: 28478995
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Adding a dopamine agonist to preexisting levodopa therapy vs. levodopa therapy alone in advanced Parkinson's disease: a meta analysis.
    Talati R; Baker WL; Patel AA; Reinhart K; Coleman CI
    Int J Clin Pract; 2009 Apr; 63(4):613-23. PubMed ID: 19222614
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Why would Parkinson's disease lead to sudden changes in creativity, motivation, or style with visual art?: A review of case evidence and new neurobiological, contextual, and genetic hypotheses.
    Lauring JO; Ishizu T; Kutlikova HH; Dörflinger F; Haugbøl S; Leder H; Kupers R; Pelowski M
    Neurosci Biobehav Rev; 2019 May; 100():129-165. PubMed ID: 30629980
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Gender differences in motor and non-motor symptoms among Sardinian patients with Parkinson's disease.
    Solla P; Cannas A; Ibba FC; Loi F; Corona M; Orofino G; Marrosu MG; Marrosu F
    J Neurol Sci; 2012 Dec; 323(1-2):33-9. PubMed ID: 22935408
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.